TrialThe Lancet. Infectious diseases2021

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.

Bihua Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.